Merck’s Next-Gen Pneumococcal Vaccine Slated for July Phase III after Two-Part Win

One of Merck’s next-generation pneumococcal vaccines has sailed through a mid-stage trial and is being readied for a Phase III study in July.
[Fierce Biotech]
Press Release

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News